Participants 58 129 4
hypertensive patients inadequately controlled by fimasartan monotherapy
Participants 413 634 6
Patients with sitting diastolic blood pressure (siDBP) â‰¥90 mmHg with 4 weeks of once-daily fimasartan 60 mg were randomly assigned to receive either once-daily fimasartan 60 mg/HCTZ 12.5 mg or fimasartan 60 mg for 4 wee
Participants 827 910 6
the 263 randomized patients, 256 patients who had available efficacy data were anal
